CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage
出版年份 2019 全文链接
标题
CX-5461 Inhibits Pancreatic Ductal Adenocarcinoma Cell Growth, Migration and Induces DNA Damage
作者
关键词
-
出版物
MOLECULES
Volume 24, Issue 24, Pages 4445
出版商
MDPI AG
发表日期
2019-12-05
DOI
10.3390/molecules24244445
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Ribosome Biogenesis—Cancer Connection
- (2019) Marianna Penzo et al. Cells
- Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease
- (2019) Varsha Prakash et al. Nature Communications
- First-in-Human RNA Polymerase I Transcription Inhibitor CX-5461 in Patients with Advanced Hematological Cancers: Results of a Phase I Dose Escalation Study
- (2019) Amit Khot et al. Cancer Discovery
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Targeting of RNA Polymerase I Transcription Using CX-5461 in Combination with Radiation Enhances Tumour Cell Killing Effects in Human Solid Cancers
- (2019) Mohammed Ismael et al. Cancers
- Possible Molecular Markers for the Diagnosis of Pancreatic Ductal Adenocarcinoma
- (2018) Quan Shen et al. MEDICAL SCIENCE MONITOR
- Targeting the ribosome biogenesis key molecule fibrillarin to avoid chemoresistance
- (2018) Btissame El Hassouni et al. CURRENT MEDICINAL CHEMISTRY
- Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma
- (2018) Øyvind H. Hald et al. ONCOGENE
- Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer
- (2017) E. Giovannetti et al. SEMINARS IN CANCER BIOLOGY
- CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours
- (2017) Hong Xu et al. Nature Communications
- The relationship between the nucleolus and cancer: Current evidence and emerging paradigms
- (2016) Ines Orsolic et al. SEMINARS IN CANCER BIOLOGY
- FOLFIRINOX and translational studies: Towards personalized therapy in pancreatic cancer
- (2016) Chiara Caparello et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Metabolite profiling stratifies pancreatic ductal adenocarcinomas into subtypes with distinct sensitivities to metabolic inhibitors
- (2015) Anneleen Daemen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Maintenance sunitinib or observation in metastatic pancreatic adenocarcinoma: A phase II randomised trial
- (2013) Michele Reni et al. EUROPEAN JOURNAL OF CANCER
- Inhibition of RNA Polymerase I as a Therapeutic Strategy to Promote Cancer-Specific Activation of p53
- (2012) Megan J. Bywater et al. CANCER CELL
- Targeting RNA Polymerase I with an Oral Small Molecule CX-5461 Inhibits Ribosomal RNA Synthesis and Solid Tumor Growth
- (2010) Denis Drygin et al. CANCER RESEARCH
- Laser microdissection and primary cell cultures improve pharmacogenetic analysis in pancreatic adenocarcinoma
- (2008) Niccola Funel et al. LABORATORY INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now